Local Representative for Foreign Medical Device Manufacturers in Belarus

1. Key takeaways

A foreign manufacturer entering Belarus needs a locally based authorised representative able to carry the submission, the regulatory communication and the post-market obligations. This is not a ceremonial arrangement. From 2026-07-30, adverse event functions were transferred to Gosfarmnadzor, and the counterpart the representative must deal with changed accordingly. A representative appointed before that date, or a mandate drafted without reference to the transfer, leaves the manufacturer with a liaison structure pointed at the wrong institution at exactly the stage when post-market duties begin to bite. The appointment therefore has to be revisited against the current institutional map, not simply renewed year after year on unchanged wording. For planning purposes, the manufacturer should treat three questions as one package: who is appointed, what the mandate covers across the product lifecycle, and which authority the representative answers to for each category of obligation. Getting all three right at the start is materially cheaper than re-papering the appointment mid-project, when submission deadlines are running against the 90 calendar day clock and every day of delay in the mandate is a day of delay in the file.

2. Legal basis

The four instruments in the table answer different halves of the representative question. Resolution No. 211 governs the registration procedure within which the representative acts; Resolution No. 378 determines which institution now receives adverse event information; the 2014 Union Agreement frames what is expected of an authorised representative when the Union route is used; and Ministry of Health Resolution No. 55 defines the mechanics of submission and acceptance that the representative must operate day to day. Reading them together is what turns a mandate document from a generic power of attorney into an instrument that actually matches the current institutional landscape.

3. Expert insights

Insight one: the value of a representative lies in being on the ground. Regulatory communication, delivery of samples, cooperation with on-site checks and post-market reporting all require someone inside Belarus able to respond immediately. Handling these matters remotely from abroad accumulates risk in timing terms — above all for responses to deficiency notices, where the 90 calendar day overall deadline for preliminary technical work leaves no slack for a mandate holder who first has to route a question across time zones, translate it, wait for instructions and then route an answer back. Companies that treat the representative as a mailing address discover the gap precisely when the clock is least forgiving.

Insight two: the function transfer of 2026-07-30 changed the liaison map for representatives. Before that date, the representative dealt principally with the expert institution; after it, the collection, registration and analysis of adverse event information and notification to the Ministry of Health are handled by Gosfarmnadzor. A representative must therefore maintain a new liaison channel for post-market matters. Companies updating their powers of attorney should reflect this change in the scope of authorisation, so that the representative is expressly entitled to deal with Gosfarmnadzor on adverse event matters. An outdated mandate that names only the former counterpart creates an authority gap that surfaces exactly when an adverse event must be processed.

Insight three: the scope of authorisation must cover the whole lifecycle. A mandate that authorises only the filing of a registration application becomes ineffective at the later stages of change notifications, adverse event reporting and certificate maintenance. The scope should be written across four segments — registration, changes, post-market, maintenance — so that a single instrument supports the product from submission to expiry. Redrawing a mandate mid-project is not merely an administrative chore: each new document may need legalisation or translation, and the interim period without a valid mandate is a period in which nobody is lawfully positioned to act for the manufacturer before the authorities.

Insight four: the representative and the distributor should not be conflated. The distributor handles commercial circulation; the representative carries statutory duties. Binding both roles onto one entity ties the statutory functions to the fate of a commercial contract, so that changing distributors forces a change in the entity holding the statutory mandate — with new documents, renewed filings and a window of exposed obligations in between. Keeping the roles separate preserves continuity of the regulatory relationship even when the commercial channel is reorganised.

4. Practical recommendations

The recommendations below translate the institutional picture into drafting instructions.

1. Write the scope of authorisation across four segments. Registration submission, change filings, post-market reporting and certificate maintenance should each be named in the mandate, so one instrument covers the lifecycle instead of expiring after the first filing.
2. Reflect the post-transfer counterpart in the mandate. State expressly that the representative is entitled to liaise with Gosfarmnadzor on adverse event matters, so the authorisation matches the institutional map in force from 2026-07-30.
3. Select the representative and the distributor separately. Avoid coupling the statutory mandate to a commercial agreement, so that replacing a distributor does not force a change in the entity holding the statutory functions.
4. Agree response time limits in the contract. Set contractual response deadlines for deficiency replies, sample delivery and report submission, protecting the 90 day overall deadline from avoidable internal delays.

5. Verification checklist

• □ The scope of authorisation covers all four segments: registration, changes, post-market and maintenance
• □ The mandate reflects the authorisation to liaise with Gosfarmnadzor on adverse events
• □ The representative and the distributor have been selected separately
• □ Response time limits for deficiency replies and report submissions have been agreed
• □ The representative has been confirmed as able to respond immediately within Belarus

Regulatory information verified as of 30 October 2026.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities on three areas. First, distinguishing between the applicability conditions and the remaining time windows of the two channels, the Union-wide registration and the national registration of each member state — the national registration procedure of Belarus has been fully re-routed by the Council of Ministers Resolution No. 211 of 28 April 2026 (state register number 6-1/55925, effective 2026-05-01), which compresses the total timeframe for preliminary technical work to 90 calendar days, keeps the list of such work closed, and prohibits the implementing organisation from expanding it, while the window for submitting applications under the national procedure takes 2027-12-31 as its key milestone, so route selection must be decided in step with the time window. Second, local authorised representative services: GRZAN can act as the statutory representative of a manufacturer in Belarus, undertaking registration submission, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison mechanisms after the Council of Ministers Resolution No. 378 of 27 July 2026 (effective 2026-07-30) transferred adverse event functions to the state agency State Pharmaceutical Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and organises technical documentation according to the target route — for the national route, per the annexes to Ministry of Health Resolution No. 55; for the Union route, per EEC Council Decision No. 46.

For business enquiries: info@grzanglobal.com